RU95101387A - Концентрированный водный раствор аргатробана - Google Patents

Концентрированный водный раствор аргатробана

Info

Publication number
RU95101387A
RU95101387A RU95101387/14A RU95101387A RU95101387A RU 95101387 A RU95101387 A RU 95101387A RU 95101387/14 A RU95101387/14 A RU 95101387/14A RU 95101387 A RU95101387 A RU 95101387A RU 95101387 A RU95101387 A RU 95101387A
Authority
RU
Russia
Prior art keywords
argatroban
aqueous solution
concentrated aqueous
substance
solution
Prior art date
Application number
RU95101387/14A
Other languages
English (en)
Other versions
RU2136282C1 (ru
Inventor
Фредерик Андрэ
Fr]
Вероник Авриль
Жан Монтель
Original Assignee
Синтелябо (FR)
Синтелябо
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Синтелябо (FR), Синтелябо filed Critical Синтелябо (FR)
Publication of RU95101387A publication Critical patent/RU95101387A/ru
Application granted granted Critical
Publication of RU2136282C1 publication Critical patent/RU2136282C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

Концентрированный водный раствор аргатробана, содержащий аргатробан, агент, формирующий мицеллы, и липоидную субстанцию.

Claims (1)

  1. Концентрированный водный раствор аргатробана, содержащий аргатробан, агент, формирующий мицеллы, и липоидную субстанцию.
RU95101387A 1994-02-03 1995-02-02 Концентрированный водный раствор аргатробана RU2136282C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9401195A FR2715566B1 (fr) 1994-02-03 1994-02-03 Solutions aqueuses concentrées d'argatroban.
FR94.01195 1994-02-03

Publications (2)

Publication Number Publication Date
RU95101387A true RU95101387A (ru) 1997-02-27
RU2136282C1 RU2136282C1 (ru) 1999-09-10

Family

ID=9459714

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95101387A RU2136282C1 (ru) 1994-02-03 1995-02-02 Концентрированный водный раствор аргатробана

Country Status (25)

Country Link
US (1) US5679690A (ru)
EP (1) EP0669131B1 (ru)
JP (1) JP3027103B2 (ru)
KR (1) KR100257692B1 (ru)
CN (1) CN1054743C (ru)
AT (1) ATE179327T1 (ru)
AU (1) AU687133B2 (ru)
CA (1) CA2141704C (ru)
CZ (1) CZ284611B6 (ru)
DE (1) DE69509279T2 (ru)
DK (1) DK0669131T3 (ru)
ES (1) ES2132547T3 (ru)
FI (1) FI950459A (ru)
FR (1) FR2715566B1 (ru)
GR (1) GR3030149T3 (ru)
HK (1) HK1013623A1 (ru)
HU (1) HU218220B (ru)
IL (1) IL112527A (ru)
NO (1) NO307324B1 (ru)
NZ (1) NZ270445A (ru)
PL (1) PL178586B1 (ru)
RU (1) RU2136282C1 (ru)
SK (1) SK12795A3 (ru)
TW (1) TW436295B (ru)
ZA (1) ZA95837B (ru)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5786153A (en) * 1996-09-12 1998-07-28 Chiron Diagnostics Corporation Prevention of probe coating on automated analyzers using a non-denaturing surfactant
WO1998053828A1 (fr) * 1997-05-27 1998-12-03 Senju Pharmaceutical Co., Ltd. Preparations aqueuses contenant de l'israpafant
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
FR2793412B1 (fr) * 1999-05-11 2001-07-27 Synthelabo Formulations galeniques d'argatroban pour administration sous-cutanee
KR100399373B1 (ko) * 2000-12-20 2003-09-26 주식회사 아이센스 콜란산 고리를 포함하는 디글라이콜릭 디아마이드 유도체,그의 제조방법 및 용도
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
EP1397068A2 (en) 2001-04-02 2004-03-17 Therasense, Inc. Blood glucose tracking apparatus and methods
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
TW200505422A (en) * 2003-03-20 2005-02-16 Mitsubishi Pharma Corp Pharmaceutical preparations containing arginine amides
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
MX2008002177A (es) * 2005-09-01 2008-04-22 Baxter Healthcare Sa Formulacion de argatroban.
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
WO2007143225A2 (en) 2006-06-07 2007-12-13 Abbott Diabetes Care, Inc. Analyte monitoring system and method
CA2662853C (en) * 2006-08-31 2016-07-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
EP2083823A4 (en) * 2006-09-27 2010-01-13 Eagle Pharmaceuticals Inc ALCOHOL-FREE FORMULATION OF ARGATROBAN
US7687516B2 (en) * 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US20100076019A1 (en) * 2006-10-11 2010-03-25 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
US8974827B2 (en) 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US7915290B2 (en) * 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
US20090221637A1 (en) * 2008-02-29 2009-09-03 Baxter International Inc. Solid-state salt argatroban formulations and methods for producing and using the same
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
WO2011026147A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte signal processing device and methods
WO2011026148A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
CN102366410B (zh) * 2011-09-14 2013-05-29 海南灵康制药有限公司 一种阿加曲班脂质体注射剂
AU2012335830B2 (en) 2011-11-07 2017-05-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US20150034098A1 (en) 2013-07-11 2015-02-05 Aqua Turf International, Inc. Air filtration mask with opening front cover
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
WO2020231791A1 (en) * 2019-05-10 2020-11-19 Fordoz Pharma Corp. Injectable polymer nanoparticle compositions of antithrombotic agents and methods thereof
CN110478471B (zh) * 2019-09-17 2020-04-10 鲁南制药集团股份有限公司 一种阿加曲班注射液及其制备方法
US20230134153A1 (en) 2020-07-03 2023-05-04 Toshiba Mitsubishi-Electric Industrial Systems Corporation Uninterruptible power supply system
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
CN113855635A (zh) * 2021-10-20 2021-12-31 陇南市第一人民医院 一种阿加曲班注射液脂质体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
JPH02129123A (ja) * 1988-11-07 1990-05-17 Mitsubishi Kasei Corp 抗血液凝固剤
CA2091715A1 (en) * 1992-03-18 1993-09-19 Mitsubishi Kasei Corporation Argatroban preparations for ophthalmic use
EP0566897A3 (en) * 1992-04-07 1994-07-06 Hoechst Ag The complete gene (cefg) encoding the acetyl-coa: deacetylcephalosporin c acetyltransferase of cephalosporium acremonium, its isolation and use

Also Published As

Publication number Publication date
ES2132547T3 (es) 1999-08-16
FI950459A (fi) 1995-08-04
AU687133B2 (en) 1998-02-19
KR100257692B1 (ko) 2000-08-01
EP0669131B1 (fr) 1999-04-28
HK1013623A1 (en) 1999-09-03
FR2715566A1 (fr) 1995-08-04
CN1109754A (zh) 1995-10-11
NO307324B1 (no) 2000-03-20
IL112527A0 (en) 1995-05-26
PL307041A1 (en) 1995-08-07
RU2136282C1 (ru) 1999-09-10
ATE179327T1 (de) 1999-05-15
JP3027103B2 (ja) 2000-03-27
CA2141704C (fr) 2001-07-03
GR3030149T3 (en) 1999-08-31
NZ270445A (en) 1995-07-26
FR2715566B1 (fr) 1996-03-08
DK0669131T3 (da) 1999-11-01
FI950459A0 (fi) 1995-02-02
JPH07277980A (ja) 1995-10-24
IL112527A (en) 1999-04-11
PL178586B1 (pl) 2000-05-31
SK12795A3 (en) 1995-08-09
CA2141704A1 (fr) 1995-08-04
HU218220B (hu) 2000-06-28
CN1054743C (zh) 2000-07-26
DE69509279T2 (de) 1999-11-25
NO950377D0 (no) 1995-02-02
EP0669131A1 (fr) 1995-08-30
DE69509279D1 (de) 1999-06-02
US5679690A (en) 1997-10-21
TW436295B (en) 2001-05-28
ZA95837B (en) 1996-03-29
NO950377L (no) 1995-08-04
CZ27195A3 (en) 1995-09-13
CZ284611B6 (cs) 1999-01-13
KR950031042A (ko) 1995-12-18
HUT71524A (en) 1995-12-28
AU1154395A (en) 1995-08-10

Similar Documents

Publication Publication Date Title
RU95101387A (ru) Концентрированный водный раствор аргатробана
RU94046294A (ru) Стероидные гликозиды для лечения гиперхолестеринэмии
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
RU94028653A (ru) Фармацевтический препарат
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
ES2133785T3 (es) Inhibidores de metaloproteinasas.
ATE163540T1 (de) Retinoid enthaltende, wässrige, gelartige darreichungsform
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE68913638T2 (de) Behandlung von wässerigen Systemen.
NZ504017A (en) Preparation of gatifloxacin and disodium edetate
HUP9904092A2 (hu) Gyógyszerkészítmény HIV és rák kezelésére valamint eljárás előállítására
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
DE59000518D1 (de) Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen.
NO912435L (no) Farmasoeytiske preparater.
DE59609508D1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
RU95101041A (ru) Липосомные растворы
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
NO954702L (no) Aryldannende medikamenter
ATE28188T1 (de) Antikonvulsive mittel.
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
CA2224565A1 (en) Agent for combating parasites in farmed fish
MY110074A (en) Pharmacuetical formulation.
ES2059633T3 (es) 2-terc.-butil-4-cloro-5-(4-terc.-butilbenciltio)-3(2h)-piridazinona para la lucha contra los moluscos.